MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry

    L. Wang, N. Prinz, A. Marcus, K. Laubner, A. Zimmerman, S. Zlamal-Fortunat, M. Sharma, R. Holl (Tübingen, Germany)

    Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…
  • 2016 International Congress

    Types of farming and prevalence and incidence of Parkinson’s disease: French nationwide study

    S. Kab, J. Spinosi, L. Chaperon, A. Dugravot, A. Singh-Manoux, F. Moisan, A. Elbaz (Saint-Maurice, France)

    Objective: We used types of farming as a proxy for pesticide exposure and investigated its association with Parkinson's disease (PD) prevalence/incidence in the entire French…
  • 2016 International Congress

    Impact of cardiovascular risk factors in the evolution and treatment of Parkinson’s disease in Mexican population

    G. Parra-López, L. Bazán-Rodríguez, M. Rodríguez-Violante, A. Cervantes-Arriaga, A. Jorge-de Sarachaga, D. Cruz-Fino, J. Pascacio-Astudillo, R. Llorens-Arenas (Mexico City, Mexico)

    Objective: To determine the role of cardiovascular risk factors such as diabetes, hypertension, obesity, dyslipidemia in the PD severity of motor and non motor symptoms,…
  • 2016 International Congress

    Jan Evangelista Purkinje: Contributions to study of anatomy and physiology of movement disorders

    R. Fekete (Valhalla, NY, USA)

    Objective: The objective is to retrieve historical articles highlighting Purkinje's research contributions. Background: Purkinje made seminal contributions to our understanding of anatomy and physiology especially…
  • 2016 International Congress

    Quality of life of Parkinson’s disease patients in a tertiary hospital in Hong Kong

    H.F. Chan, Y.F. Cheung, D.K.W. Chau, T. Fung, I. Chan, W.C. Fong (Hong Kong, Hong Kong)

    Objective: 1. To evaluate the quality of life (QoL) profile of Parkinson's disease (PD) patients in a multidisciplinary clinic in a tertiary hospital in Hong…
  • 2016 International Congress

    Developing palliative care clinics for patients with advanced Parkinson’s disease: Practical approaches, challenges, and experiences

    C.L. Dietiker, N.B. Galifianakis, M. Katz, S.L. Heath (San Francisco, CA, USA)

    Objective: To describe the development of palliative care clinics for patients with advanced Parkinson's disease (PD) in two diverse settings with a qualitative focus on…
  • 2016 International Congress

    Twelve-week sensor assessment in Parkinson’s disease: Impact on quality of life

    J.M.T. Van Uem, K.S. Maier, A.T. Santos, O. Fagerbakke, F. Larsen, J.J. Ferreira, W. Maetzler (Tübingen, Germany)

    Objective: To evaluate the effects of using wearables over a long time period on Health-Related Quality of Life (HRQoL) in Parkinson's disease (PD) patients. Background:…
  • 2016 International Congress

    A validation study of a smartphone-based finger tapping application for quantitative assessment of bradykinesia in Parkinson’s disease

    C.Y. Lee, S.J. Kang, Y.E. Kim, U. Lee, H.I. Ma, Y.J. Kim (Anyang-si, Gyeonggi-do, Korea)

    Objective: We developed an application of smartphone tapper (SmpT) and sought to determine whether SmpT is applicable for clinical purpose by comparing SmpT parameters to…
  • 2016 International Congress

    Survey of telemedicine use among MDS members

    A. Hassan, E.R. Dorsey, E. Cubo, C.G. Goetz, B.R. Bloem, M. Guttman, S.L. Heath, M. Katz, M. Spinder, C.M. Tanner, Z. Mari, A. Pantelyat, J.A. Bajwa, N.B. Galifianakis, E.M. Gatto (Rochester, MN, USA)

    Objective: To evaluate telemedicine use amongst global members of the International Parkinson and Movement Disorders Society (MDS). Background: The current utilization of telemedicine by healthcare…
  • 2016 International Congress

    TAF1 and its isoforms is underexpressed in different endogenous models of X-linked dystonia-parkinsonism

    A. Domingo, K. Grütz, P. Seibler, P. Capetian, L.V. Lee, R. Rosales, R.D. Jamora, A. Westenberger, A. Rakovic, C. Klein (Lübeck, Germany)

    Objective: To study the expression of TAF1 and its isoforms in different endogenous models of X-linked dystonia-parkinsonism (XDP). Background: The putative gene causing XDP, the…
  • « Previous Page
  • 1
  • …
  • 157
  • 158
  • 159
  • 160
  • 161
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Unusual prolonged survival in multiple system atrophy: A case report
  • An atypical and interesting feature of Parkinson´s disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley